pharma · Phelan-McDermid Syndrome
Jiangnan University
Affiliated Hospital of Jiangnan University
Affiliated Hospital of is a pharma organization headquartered in CN. Primary therapeutic focus areas include Phelan-McDermid Syndrome. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s)
CN HQ
1902 Founded
1,230 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Founded
- 1902
- Employees
- 1,230
- Programs
- 1
- Drugs
- 1
- Patents
- 0
recombinant human growth hormone
Phase 2 · small molecule · Phelan-McDermid Syndrome
recombinant human growth hormone for Phelan-McDermid Syndrome is a Phase 2 program (small_molecule) at Affiliated Hospital of Jiangnan University with 1 ClinicalTrials.gov record(s).
Internal code 395779225
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Affiliated Hospital of Jiangnan University
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Phelan-McDermid Syndrome
- Status
- completed
- Trials
- 1